More than 1,000 health care workers at Crystal Run voted overwhelmingly to unionize, but their employer, Optum, is trying to ...

There were 122 National Labor Relations Board representation elections run in February 2025, and ten involved units of 250 or ...

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

These changes are part of ongoing efforts to reduce total UnitedHealthcare prior authorization volume," the company said.

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...

Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.

UnitedHealthcare is eliminating prior authorization requirements for certain home health services provided under Medicare Advantage plans as part of a ...

Vertex Pharmaceuticals’ (VRTX) non-opioid pain drug Journavx was picked up by UnitedHealth’s (UNH) Optum on “Tier 3.” The insurer said, ...

The federal government has been cracking down on healthcare giant UnitedHealth Group over the past year, and it’s showing no signs of slowing down. This week, the company faced two new ...

Optum Rx, a pharmacy benefit manager owned by one of the country’s largest insurance companies, UnitedHealth Group, has added a new, much-anticipated pain drug to some of its commercial ...